# Inovio Pharmaceuticals, Inc.: Form 8-K, filed Oct 6, 2026

- Company: [Inovio Pharmaceuticals, Inc.](/companies/ino.md) (CIK 1055726)
- Form: 8-K
- Filed: 2026-10-06
- Accepted by EDGAR: Oct 6, 2026, 16:06 ET
- Period: 2026-10-06
- Accession: 0001193125-26-415555
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1055726/000119312526415555/d127604d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1055726/000119312526415555/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1055726/000119312526415555/d127604d8k.htm

Filed Oct 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-415555. Last ingested by Listed: Nov 9, 2026, 17:37 ET. No prices; not investment advice.